Related Experiment Video
Updated: Feb 16, 2026

An Orthotopic Murine Model of Human Prostate Cancer Metastasis
Published on: September 18, 2013
Epigenetic Changes Induced by Green Tea Catechins a re Associated with Prostate Cancer
A Giudice1, M Montella1, M Boccellino2
1Epidemiology Unit, National Cancer Institute of Naples "G. Pascale Foundation", IRCCS, 80131 Naples, Italy.
Abstract:
Prostate cancer is one of the most difficult cancers to treat especially when it becomes hormone resistant such as castrate resistant prostate cancer (CRPC) and subsequent metastatic CRPC. Apart from the genetic alterations in prostate cancer, epigenetic modifications also play an important role in the development and neoplastic progression of this disease. These include DNA methylation, histone modifications, and non-coding microRNAs. miRNAs are a novel class of small endogenous single-stranded non-coding RNAs of 19-25 nucleotides in length that typically silence gene expression. Considering the reversibility of epigenetic alterations in early carcinogenesis process, reversion (correction) of these modifications by green tea catechins could be a promising strategy for cancer chemoprevention and therapy. Recent evidence suggests that green tea catechins such as epigallocatechin gallate (EGCG) not only act as epigenetic modulators but can also modify miRNA expression and their target mRNAs, consistently contributing to the inhibition of prostate carcinogenesis. Various studies also indicate that several green tea polyphenols (GTPs) exert synergistic effects with other cancer chemotherapeutic agents. Therefore, the use of appropriate combinations of green tea catechins with the existing chemotherapeutics will lead to a reduction in side effects without decreasing the chemotherapeutic effects. This review will summarize the key results from recent studies detailing the effects of green tea catechins such as EGCG on epigenetic alterations and miRNA expression in prostate cancer.
Insights
Green tea catechins, like EGCG, show promise in treating prostate cancer by reversing epigenetic changes and modulating miRNA expression. These natural compounds may enhance chemotherapy effectiveness and reduce side effects.
Area of Science:
- Oncology
- Epigenetics
- Molecular Biology
Background:
- Prostate cancer, particularly castrate-resistant (CRPC), presents significant treatment challenges.
- Epigenetic modifications, including DNA methylation, histone modifications, and microRNAs (miRNAs), are crucial in prostate cancer development and progression.
- miRNAs are small non-coding RNAs that regulate gene expression, impacting cancer pathways.
Purpose of the Study:
- To review the role of green tea catechins in modulating epigenetic alterations and miRNA expression in prostate cancer.
- To explore the potential of green tea catechins, such as epigallocatechin gallate (EGCG), as chemopreventive and therapeutic agents.
- To summarize evidence on the synergistic effects of green tea polyphenols (GTPs) with conventional chemotherapeutics.
Main Methods:
- Literature review of recent studies on green tea catechins, epigenetics, and prostate cancer.
- Analysis of research investigating EGCG's effects on DNA methylation, histone modifications, and miRNA expression.
- Examination of studies on the combined use of GTPs and chemotherapeutic agents.
Main Results:
- Green tea catechins, particularly EGCG, demonstrate epigenetic modulatory effects, including influencing DNA methylation and histone modifications.
- EGCG impacts miRNA expression and targets messenger RNAs (mRNAs), contributing to the inhibition of prostate cancer cell growth.
- Green tea polyphenols exhibit synergistic effects when combined with standard cancer chemotherapeutics, potentially reducing toxicity.
Conclusions:
- Green tea catechins represent a promising natural strategy for prostate cancer chemoprevention and therapy due to their epigenetic and miRNA-modulating activities.
- Combining green tea catechins with existing chemotherapeutics may enhance treatment efficacy while mitigating adverse side effects.
- Further research into EGCG and other GTPs could lead to novel therapeutic combinations for managing prostate cancer, especially CRPC.
Related Concept Videos
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Cancer Prevention
Some...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Mutagenicity and Carcinogenicity
Epigenetic Regulation
X-chromosome...

